Inventor profile of:

Raphael MECHOULAM

City:

Jerusalem

Country:

Israel

Published Applications:

41

Last publication date:

2026-01-29

Top Assignees for applications by Raphael MECHOULAM

The entities that hold a legal rights for patent applications filed by inventor MECHOULAM Raphael:

Recent patent applications by MECHOULAM Raphael

Raphael MECHOULAM from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-29
US20260027079A1
Human necessities

CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF

#2 | 2024-04-11
US20240116883A1
Chemistry; metallurgy

CANNABINOID DERIVATIVES AND THEIR USE THE TREATMENT OF INFLAMMATION AND/OR PAIN AND/OR OBESITY

#3 | 2023-06-29
US20230202964A1
Chemistry; metallurgy

CANNABIGEROLIC ACID (CDGA) DERIVATIVES AND USES THEREOF

#4 | 2023-06-22
US20230192588A1
Chemistry; metallurgy

CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF

#5 | 2022-05-19
US20220151972A1
Human necessities

CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF

#6 | 2022-04-14
US20220110901A1
Human necessities

FATTY ACID AMIDES AND USES THEREOF IN THE TREATMENT OF NAUSEA

#7 | 2022-01-06
US20220000814A1
Human necessities

METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME

#8 | 2021-12-09
US20210379010A1
Human necessities

COMPOSITIONS COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF BIOFILM AND CONDITIONS ASSOCIATED WITH MICROBIAL, FUNGAL, BACTERIAL INFECTIONS

#9 | 2020-04-16
US20200115317A1
Chemistry; metallurgy

Cannabidiolic acid esters compositions and uses thereof

#10 | 2020-04-09
US20200108037A1
Human necessities

Fatty acid amides and uses thereof in the treatment of addiction disorder and addiction related conditions

#11 | 2019-06-06
US20190169148A1
Chemistry; metallurgy

Method for treating pain or associated condition or symptom

#12 | 2019-05-23
US20190151264A1
Human necessities

Methods for treatment of Prader-Willi syndrome

#13 | 2019-03-21
US20190084909A1
Chemistry; metallurgy

FLUORINATED CBD COMPOUNDS, COMPOSITIONS AND USES THEREOF

#14 | 2018-04-05
US20180093959A1
Chemistry; metallurgy

Cyclohexenyl compounds, compositions comprising them and uses thereof

#15 | 2017-11-16
US20170326078A1
Human necessities

Fluorinated CBD compounds, compositions and uses thereof

#16 | 2017-07-13
US20170197904A1
Chemistry; metallurgy

Fluorinated CBD compounds, compositions and uses thereof

#17 | 2017-02-02
US20170029391A1
Chemistry; metallurgy

CYCLOHEXENYL COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS

#18 | 2015-12-03
US20150344403A1
Chemistry; metallurgy

Fluorinated CBD compounds, compositions and uses thereof

#19 | 2015-02-05
US20150038728A1
Chemistry; metallurgy

Arylated camphenes, processes for their preparation and uses thereof

#20 | 2013-07-25
US20130190393A1
Chemistry; metallurgy

USES OF INCENSOLE, INCENSOLE ACETATE AND DERIVATIVES THEREOF

#21 | 2012-09-27
US20120245366A1
Chemistry; metallurgy

Arylated camphenes, processes for their preparation and uses thereof

#22 | 2011-11-03
US20110269842A1
Chemistry; metallurgy

Compositions comprising CB receptor agonists, uses thereof and methods for their preparation

#23 | 2011-10-13
US20110251290A1
Human necessities

Treatment of hepatic encephalopathy and liver cirrhosis

#24 | 2011-04-21
US20110092584A1
Chemistry; metallurgy

Compositions including quinonoid derivatives of cannabinoids for therapeutic use

#25 | 2011-02-24
US20110046222A1
Chemistry; metallurgy

Fatty acid amides and uses thereof

#26 | 2010-09-02
US20100222438A1
Human necessities

METHODS COMPOSITIONS AND ARTICLE OF MANUFACTURE FOR MODULATING BONE GROWTH

#27 | 2010-07-20
US10311554
-

Pharmaceutical compositions comprising cannabidiol derivatives

#28 | 2010-06-24
US20100158973A1
Human necessities

THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS

#29 | 2010-06-17
US20100152238A1
Chemistry; metallurgy

NOVEL QUINONOID DERIVATIVES OF CANNABINOIDS AND THEIR USE IN THE TREATMENT OF MALIGNANCIES

#30 | 2010-04-22
US20100099756A1
Chemistry; metallurgy

USES OF INCENSOLE, INCENSOLE ACETATE AND DERIVATIVES THEREOF

#31 | 2010-01-28
US20100022631A1
Human necessities

Treatment of hepatic encephalopathy and liver cirrhosis

#32 | 2008-11-06
US20080275135A1
Human necessities

Resorcinol Derivatives and Their Use for Lowering Blood Pressure

#33 | 2008-09-11
US20080221339A1
Chemistry; metallurgy

CONVERSION OF CBD TO DELTA8-THC AND DELTA9-THC

#34 | 2007-05-03
US20070099987A1
Human necessities

Treating or preventing diabetes with cannabidiol

#35 | 2007-04-12
US20070082954A1
Chemistry; metallurgy

Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives

#36 | 2007-03-01
US20070049645A1
Human necessities

Anti-nausea and anti-vomiting activity of cannabidiol compounds

#37 | 2005-11-24
US20050260608A1
Chemistry; metallurgy

Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis

#38 | 2005-07-28
US20050165118A1
Human necessities

Agonists specific for the peripheral cannabinoid receptor

#39 | 2005-06-23
US20050137159A1
Human necessities

Methods compositions and articles of manufacture for modulating bone growth

#40 | 2005-06-07
US10133153
-

Agonists specific for the peripheral cannabinoid receptor

#41 | 2005-03-08
US9698071
-

Agonists specific for the peripheral cannabinoid receptor

InventorID:

355802 ⎘